World Library  


Add to Book Shelf
Flag as Inappropriate
Email this Book

Plos One : Combined Approaches for Drug Design Points the Way to Novel Proline Racemase Inhibitor Candidates to Fight Chagas’ Disease, Volume 8

By Taylor, Paul

Click here to view

Book Id: WPLBN0003945544
Format Type: PDF eBook :
File Size:
Reproduction Date: 2015

Title: Plos One : Combined Approaches for Drug Design Points the Way to Novel Proline Racemase Inhibitor Candidates to Fight Chagas’ Disease, Volume 8  
Author: Taylor, Paul
Volume: Volume 8
Language: English
Subject: Journals, Science, Medical Science
Collections: Periodicals: Journal and Magazine Collection (Contemporary)
Historic
Publication Date:
Publisher: Plos

Citation

APA MLA Chicago

Taylor, P. (n.d.). Plos One : Combined Approaches for Drug Design Points the Way to Novel Proline Racemase Inhibitor Candidates to Fight Chagas’ Disease, Volume 8. Retrieved from http://www.nationalpubliclibrary.info/


Description
Description : Chagas’ disease is caused by Trypanosoma cruzi, a protozoan transmitted to humans by blood-feeding insects, blood transfusion or congenitally. Previous research led us to discover a parasite proline racemase (TcPRAC) and to establish its validity as a target for the design of new chemotherapies against the disease, including its chronic form. A known inhibitor of proline racemases, 2-pyrrolecarboxylic acid (PYC), is water-insoluble. We synthesized soluble pyrazole derivatives, but they proved weak or inactive TcPRAC inhibitors. TcPRAC catalytic site is too small and constrained when bound to PYC to allow efficient search for new inhibitors by virtual screening. Forty-nine intermediate conformations between the opened enzyme structure and the closed liganded one were built by calculating a transition path with a method we developed. A wider range of chemical compounds could dock in the partially opened intermediate active site models in silico. Four models were selected for known substrates and weak inhibitors could dock in them and were used to screen chemical libraries. Two identified soluble compounds, (E)-4-oxopent-2-enoic acid (OxoPA) and its derivative (E)-5-bromo-4-oxopent-2- enoic acid (Br-OxoPA), are irreversible competitive inhibitors that presented stronger activity than PYC on TcPRAC. We show here that increasing doses of OxoPA and Br-OxoPA hamper T. cruzi intracellular differentiation and fate in mammalian host cells. Our data confirm that through to their binding mode, these molecules are interesting and promising as lead compounds for the development of chemotherapies against diseases where active proline racemases play essential roles.

 

Click To View

Additional Books


  • Plos One : the Characterisation of Pax3 ... (by )
  • Plos One : Continuous Influenza Virus Pr... (by )
  • Plos One : the Abundance and Pollen Fora... (by )
  • Plos One : Multimodal Floral Signals and... (by )
  • Plos One : Invariance of Visual Operatio... (by )
  • Plos One : Flgm as a Secretion Moiety fo... (by )
  • Plos One : the Effect of Sod1 Mutation o... (by )
  • Plos One : Outcomes and Impact of Hiv Pr... (by )
  • Plos One : Impact of Preventive Response... (by )
  • Plos One : the Coupstu and Tarpqm Transp... (by )
  • Plos One : Molecular Evidence Shows Low ... (by )
  • Plos One : Mutational Analysis of the Te... (by )
Scroll Left
Scroll Right

 



Copyright © World Library Foundation. All rights reserved. eBooks from National Public Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.